← back to search

Josef Bednařík

University of Illinois Chicago · CZ
Area of research
Surgery · Pathology and Forensic Medicine
Research interest
Research interests include Cervical and Thoracic Myelopathy, Spine and Intervertebral Disc Pathology, Pain Mechanisms and Treatments, and Education, Psychology, and Social Research.
h-index
42
citations
6,848
works
625
NIH funding
primary concept
Medicine
email

Recent publications

Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial
Nature Medicine 2026cited by 4position: lastdoi
A Controlled Single-Centre Pilot Study to Evaluate the Effect of Prophylactic Surgery in Asymptomatic Degenerative Cervical Cord Compression.
2025cited by 2position: contributordoi
A Systematic Review of Current Terminology for Conditions Preceding Degenerative Cervical Myelopathy: Evidence Synthesis to Inform an AO Spine Expert Opinion Statement.
2025cited by 2position: contributordoi
Dermatomal Contact Heat Evoked Potentials for the Detection of Subclinical Cervical Spinal Cord Injury in Asymptomatic Degenerative Cervical Cord Compression.
2025cited by 0position: contributordoi
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
New England Journal of Medicine 2024cited by 604position: lastdoi
Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial
Contemporary Clinical Trials 2024cited by 69position: middledoi
Screening and differential diagnosis of delirium in neurointensive stroke patients.
2024cited by 1position: contributordoi
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
2023cited by 17position: contributordoi
0567 Tirzepatide for the Treatment of OSA: Rationale and Design of the SURMOUNT-OSA Phase 3 Trial
SLEEP 2023cited by 7position: middledoi
Degenerative Cervical Myelopathy: Development and Natural History [AO Spine RECODE-DCM Research Priority Number 2]
Global Spine Journal 2022cited by 76position: middledoi
A New Framework for Investigating the Biological Basis of Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 5]: Mechanical Stress, Vulnerability and Time
Global Spine Journal 2022cited by 58position: middledoi
A New Framework for Investigating the Biological Basis of Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 5]: Mechanical Stress, Vulnerability and Time.
2022cited by 39position: contributordoi
Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain
European Journal of Pain 2022cited by 15position: lastdoi
Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross-sectional study.
2022cited by 15position: contributordoi
Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain.
2022cited by 9position: contributordoi
Predictors of Short- and Long-Term Mortality in Ischemic Stroke: A Community-Based Study in Brno, Czech Republic.
2022cited by 6position: contributordoi
Quantitative MR Markers in Non-Myelopathic Spinal Cord Compression: A Narrative Review.
2022cited by 4position: contributordoi
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
The Lancet Neurology 2021cited by 645position: middledoi
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
2021cited by 57position: contributordoi
Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross‐sectional study
European Journal of Pain 2021cited by 30position: middledoi
Diffusion magnetic resonance imaging reveals tract-specific microstructural correlates of electrophysiological impairments in non-myelopathic and myelopathic spinal cord compression.
2021cited by 25position: contributordoi
Incidence of Stroke and Ischemic Stroke Subtypes: A Community-Based Study in Brno, Czech Republic.
2021cited by 15position: contributordoi
Vertigo in Patients with Degenerative Cervical Myelopathy.
2021cited by 6position: contributordoi
Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
2020cited by 22position: contributordoi
HARDI-ZOOMit protocol improves specificity to microstructural changes in presymptomatic myelopathy.
2020cited by 20position: contributordoi
Trends in One Month and One Year Hemorrhagic Stroke Case Fatality Rates in the Czech Republic between 1998 and 2015.
2020cited by 3position: contributordoi
Voxelwise analysis of diffusion MRI of cervical spinal cord using tract-based spatial statistics.
2020cited by 2position: contributordoi
The Association of methylprednisolone dosing to cessation of myotonia in a patient with myotonic dystrophy type 1.
2020cited by 0position: contributordoi
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
2019cited by 178position: contributordoi
What is normal trauma healing and what is complex regional pain syndrome I? An analysis of clinical and experimental biomarkers
Pain 2019cited by 56position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 15 papers (2020–2025)Claudia Sommer · University of Lausanne9 papers (2013–2022)Frank Birklein · Johannes Gutenberg University Mainz7 papers (2013–2022)Eva Vlčková · Johannes Gutenberg University Mainz6 papers (2017–2022)Nurcan Üçeyler · Apple (Israel)6 papers (2013–2022)Jan Valosek · Mila - Quebec Artificial Intelligence Institute4 papers (2020–2025)Heike L. Rittner · Johannes Gutenberg University Mainz4 papers (2013–2019)Petra Sedova · Publons3 papers (2020–2022)Petr Bednarik · Medical University of Vienna3 papers (2020–2022)Eva Vlckova · Masaryk University3 papers (2021–2025)Magda Horakova · Masaryk University3 papers (2020–2022) · 3 papers (2019–2022)Atul Malhotra · Monash Health3 papers (2023–2024)Michael G. Fehlings · Regenerative Medicine Institute3 papers (2022–2022) · 3 papers (2017–2022)Sujatro Chakladar · Eli Lilly (United States)3 papers (2024–2026)Julia P. Dunn · Eli Lilly (United States)3 papers (2023–2024) · 3 papers (2017–2022) · 2 papers (2017–2021) · 2 papers (2017–2021)